CEBPA Overexpression Enhances β-Cell Proliferation and Survival.

Area of Science:

• Endocrinology
• Molecular Biology
• Diabetes Research

Background:

• Type 1 and type 2 diabetes are characterized by a loss of functional beta-cell mass.
• The transcription factor Nkx6.1 is essential for beta-cell development and function.
• Nkx6.1's role in beta-cell function involves c-Fos and nuclear hormone receptors Nr4a1/Nr4a3 for insulin secretion, survival, and replication.

Purpose of the Study:

• To investigate the role of Nkx6.1 in regulating other transcription factors.
• To determine if CCAAT enhancer-binding protein alpha (CEBPA) can enhance functional beta-cell mass.
• To elucidate the mechanisms by which CEBPA influences beta-cell proliferation, survival, and response to endoplasmic reticulum (ER) stress.

Main Methods:

• Overexpression of Nkx6.1 in beta-cells to assess CEBPA expression.
• Overexpression of CEBPA in INS-1 832/13 cells and primary rat islets to evaluate proliferation and survival.
• Treatment of beta-cells with thapsigargin to induce ER stress and analysis of gene expression, including Ire1a.

Main Results:

• Nkx6.1 overexpression leads to the upregulation of the bZip transcription factor CEBPA, independently of c-Fos.
• CEBPA overexpression is sufficient to increase proliferation in both beta-cell lines and primary islets.
• CEBPA enhances beta-cell survival under ER stress conditions, associated with altered expression of unfolded protein response genes like Ire1a.

Conclusions:

• CEBPA is a downstream target of Nkx6.1 and plays a significant role in beta-cell biology.
• CEBPA is sufficient to promote beta-cell proliferation and enhance survival.
• CEBPA modulates the unfolded protein response, contributing to increased functional beta-cell mass.